Sputum matrix metalloproteinase-8 and -9 and tissue inhibitor of metalloproteinase-1 in bronchiectasis: Clinical correlates and prognostic implications

Respirology

Volumn 20, Issue 7, 2015, Pages 1073-1081

  Guan, Wei Jie ^a   Gao, Yong Hua ^d   Xu, Gang ^b   Lin, Zhi Ya ^a   Tang, Yan ^a   Gu, Ying Ying ^a   Liu, Gui Hong ^c   Li, Hui Min ^a   Chen, Rong Chang ^a   Zhong, Nan Shan ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c Panyu Central Hospital   (China)

^d THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Bronchiectasis; bronchiectasis exacerbation; disease severity; lung function; matrix metalloproteinase

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; MATRIX METALLOPROTEINASE INHIBITOR; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BRONCHIECTASIS; BRONCHIECTASIS SEVERITY INDEX; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT DISEASE ASSESSMENT; RISK ASSESSMENT; RISK REDUCTION; SPIROMETRY; SPUTUM LEVEL; SURVIVAL; CHINA; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; SPUTUM;

ADULT; AGED; BIOMARKERS; BRONCHIECTASIS; CHINA; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROGNOSIS; SPIROMETRY; SPUTUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84941601290     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12582     Document Type: Article

References (26)

1. Baker AF,. Bronchiectasis. N. Engl. J. Med. 2002; 346: 1383-1393.
2. Zheng L, Lam WK, Tipoe G, Shum IH, Yan C, Leung R, Sun J, Ooi GC, Tsang KW,. Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo. Eur. Respir. J. 2002; 20: 170-176.
3. Sepper R, Konttinen YT, Sorsa T, Koski H,. Gelatinolytic and type IV collagenolytic activity in bronchiectasis. Chest 1994; 106: 1129-1133.
4. Sepper R, Konttinen YT, Ding YL, Takaqi M, Sorsa T,. Human neutrophil collagenase (MMP-8), identified in bronchiectasis BAL fluid, correlates with severity of disease. Chest 1995; 107: 1641-1647.
5. Goeminne PC, Vandooren J, Moelants EA, Decraene A, Rabaey E, Pauwels A, Seys S, Opdenakker G, Proost P, Dupont LJ,. The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis. Respirology 2014; 19: 203-210.
6. Gaggar A, Li Y, Weathington N, Winkler M, Kong M, Jackson P, Blalock JE, Clancy JP,. Matrix metalloproteinase-9 dysregulation in lower airway secretions of cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 293: L96-104.
7. Taylor SL, Rogers GB, Chen AC, Burr LD, McGuckin MA, Serisier DJ,. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis. Ann. Am. Thorac. Soc. 2015; 12: 701-707.
8. Jin Q, Huang FH, Zhou Y, Zhang YQ, Chai XJ,. Effect of Pseudomonas aeruginosa on the expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the airways of bronchiectasis patients. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2012; 34: 384-389.
9. Li NG, Tang YP, Duan JA, Shi ZH,. Matrix metalloproteinase inhibitors: a patent review (2011-2013). Expert Opin. Ther. Pat. 2014; 24: 1039-1052.
10. Vandenbroucke RE, Libert C,. Is there new hope for therapeutic matrix metalloproteinase inhibition? Nat. Rev. Drug Discov. 2014; 13: 904-927.
11. Pasteur MC, Bilton D, Hill AT, on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guideline Group. British Thoracic Society guidelines for non-CF bronchiectasis. Thorax 2010; 65: i1-58.
12. Tsang KW, Tan KC, Ho PL, Ooi GC, Ho JC, Mak J, Yipoe GL, Ko C, Yan C, Lan WK, et al., Inhaled fluticasone in bronchiectasis: a 12 month study. Thorax 2005; 60: 239-243.
13. Tsang KW, Ho PL, Lam WK, Ip MS, Chan KN, Ho CS, Ooi CC, Yuen KY,. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am. J. Respir. Crit. Care Med. 1998; 158: 723-727.
14. Guan WJ, Gao YH, Xu G, Lin ZY, Tang Y, Li HM, Lin ZM, Zheng JP, Chen RC, Zhong NS,. Capsaicin cough sensitivity and the association with clinical parameters in bronchiectasis. PLoS ONE 2014; 9: e113057.
15. Gao YH, Guan WJ, Xu G, Lin ZY, Tang Y, Li HM, Lin ZM, Zheng JP, Chen RC, Zhong NS,. Validation of the Mandarin-Chinese version of Leicester Cough Questionnaire in bronchiectasis. Int. J. Tuberc. Lung Dis. 2014; 18: 1431-1437.
16. Gao Y, Guan W, Xu G, Lin Z, Tang Y, Lin Z, Gao Y, Li H, Zhong N, Zhang G, et al., The role of viral infection in pulmonary exacerbations of bronchiectasis in adults: a prospective study. Chest 2015; 147: 1635-1643.
17. Guan WJ, Gao YH, Xu G, Lin ZY, Tang Y, Li HM, Lin ZM, Zheng JP, Chen RC, Zhong NS,. Sputum bacteriology in steady-state bronchiectasis in Guangzhou, China. Int. J. Tuberc. Lung Dis. 2015; 19: 610-619.
18. Guan WJ, Gao YH, Xu G, Lin ZY, Tang Y, Li HM, Lin ZM, Zheng JP, Chen RC, Zhong NS,. Impulse oscillometry in adults with bronchiectasis. Ann Am Thorac Soc 2015; 12: 657-665.
19. Guan WJ, Gao YH, Xu G, Lin ZY, Tang Y, Li HM, Lin ZM, Zheng JP, Chen RC, Zhong NS,. Six-minute walk test in Chinese adults with stable bronchiectasis: association with clinical indices and determinants. Curr. Med. Res. Opin. 2015; 31: 843-852.
20. Guan WJ, Gao YH, Xu G, Lin ZY, Tang Y, Li HM, Lin ZM, Zheng JP, Chen RC, Zhong NS,. Aetiology of bronchiectasis in Guangzhou, southern China. Respirology 2015; 20: 739-748.
21. Tunney MM, Einarsson GG, Wei L, Drain M, Klem ER, Cardwell C, Ennis M, Boucher RC, Wolfgang MC, Elborn JS,. The lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am. J. Respir. Crit. Care Med. 2013; 187: 1118-1126.
22. Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, Poppelwell L, Salih W, Pesci A, Dupont LJ, et al., The bronchiectasis severity index: an international derivation and validation study. Am. J. Respir. Crit. Care Med. 2014; 189: 576-585.
23. Chan SC, Shum DK, Ip MS,. Sputum sol neutrophil elastase activity in bronchiectasis: differential modulation by syndecan-1. Am. J. Respir. Crit. Care Med. 2003; 168: 192-198.
24. Sepper R, Konttinen YT, Buo L, Eklund KK, Lauhio A, Sorsa T, Tschesche H, Aasen AO, Sillastu H,. Potentiative effects of neutral proteinases in an inflamed lung: relationship of neutrophil procollagenase (proMMP-8) to plasmin, cathepsin G and tryptase in bronchiectasis in vivo. Eur. Respir. J. 1997; 10: 2788-2793.
25. Guan WJ, Gao YH, Xu G, Lin ZY, Tang Y, Li HM, Lin ZM, Zheng JP, Chen RC, Zhong NS,. Characterization of lung function impairment in adults with bronchiectasis. PLoS ONE 2014; 9: e113373.
26. Liu Y, Wang L, Tian X, Xu KF, Xu W, Li X, Yue C, Zhang P, Xiao Y, Zhang X,. Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients. Respirology 2015; 20: 312-318.